Intrauterine insemination (IUI) as a type of artificial insemination involves the placement of sperm directly into the uterus at the time of ovulation, either in a natural menstrual cycle or following ovarian stimulation. The process allows the concentration of sperm in a small volume of culture media and then the concentrated sperm is placed into the uterus through a transcervical catheter. IU...

To assess whether high BMI of >30kg/m2 affects outcome Intrauterine Insemination method(IUI). We conducted a retrospective study 140 infertile couples. Out these 71 women had <30 (Group A) and 69 >30 B). All undergone (IUI) using the agonist/antagonist with stimulation by gonadotrophins protocol. Statistical anylasis was done Student t test for parametric data Chi-square...

Background: Infertility is unexplained in about 22% - 28% of infertile couples. Spontaneous pregnancy may occur them. If did not happen, Expectant management will be via clomiphene citrate (CC) administration, intrauterine insemination (IUI), and IVF & ICSI. Aim: to assess the effectiveness with mild controlled ovarian stimulation compared expectant couples infertility more than one year. Metho...

BACKGROUND Overactive bladder is a prevalent and burdensome condition. Generic utility measures may fail to reflect its full impact on patients' health status. The Incontinence Utility Index (IUI) is a community-based preference index derived from the Incontinence Quality of Life Questionnaire (I-QOL) developed to value health states related to urinary symptoms in patients with neurogenic detru...

OBJECTIVE To investigate the optimum number of cycles of controlled ovarian hyperstimulation and intrauterine insemination in the treatment of unexplained infertility. DESIGN Observational prospective study. SETTING In vitro fertilization embryo transfer center. PATIENT(S) Five hundred ninety-four couples with unexplained infertility. INTERVENTION(S) Controlled ovarian hyperstimulation ...

BACKGROUND The aim of this study, we have compared the advantages of oral dydrogestrone with vaginal progesterone (cyclogest) for luteal support in intrauterine insemination (IUI) cycles. Progesterone supplementation is the first line treatment when luteal phase deficiency (LPD) can reasonably be assumed. OBJECTIVE This study was conduct to compare the effect of oral dydrogestrone with vagina...

IUI ) " DE * F G! ( +H I >J * $ * : A ** + K$ L 8 , G * M $ 6 * * *$ N O(7E P 7 > G8$ < * ; Q R7 . ! : -6 S: T * 793+ 6 + S J) U ; < : = * D% " 2 V 2 S 79 * 9 6 *$ 9 1 A . >L IUI W V 9 7 9 X1 swim up 78 + % 9 G Y1$7 Z RE V + * ; 6 7 1 . 4 J N X1 6 7 78 + % 1 * $ ! " #$% < Q . ! : [ 140 D 1 95 #$_ [ * A 7_9 * _% Y_1$7 Z_ RE V _+ * * 2 ` ) 5 / 18 , * ( 26 D 1 6 * $ 3 / 27 , * * *...

Intrauterine insemination (IUI) as a type of artificial insemination involves the placement of sperm directly into the uterus at the time of ovulation, either in a natural menstrual cycle or following ovarian stimulation. The process allows the concentration of sperm in a small volume of culture media and then the concentrated sperm is placed into the uterus through a transcervical catheter. IU...

BACKGROUND Although the motile sperm organelle morphology examination (MSOME) was developed merely as a selection criterion, its application as a method for classifying sperm morphology may represent an improvement in the evaluation of semen quality. The aim of this study was to determine the prognostic value of normal sperm morphology using MSOME with regard to clinical pregnancy (CP) after in...